ARA 290 is a peptide derived from the hormone erythropoietin (EPO), which is responsible for stimulating the production of red blood cells.

ARA 290 is a small peptide molecule that was developed as an anti-inflammatory agent. This peptide is also used to treat various conditions such as diabetic neuropathy, chronic kidney disease, and others.

ARA 290 peptide was developed as an analogue of the hematopoietic protein erythropoietin (EPO), which is used to stimulate the production of red blood cells. It binds to the EPO Erythropoietin receptors, making it an immunomodulator and anti-inflammatory agent, rather than directly stimulating the production of red blood cells.

What are the benefits of ARA 290 Peptide?

The use of ARA 290 peptide has the following benefits for the body and organism:

ARA 290 helps with pain and neuropathic symptoms due to diabetic neuropathy, by relieving pain and improving nerve function.

ARA-290 is used to improve cognitive function and reduce inflammation associated with Alzheimer's disease.
Peptide ARA 290 improves kidney function and reduces inflammation associated with chronic kidney disease.
This peptide has anti-inflammatory properties, making it useful in combating inflammation caused by certain diseases.
Minor side effects and low toxicity are observed with the use of peptide ARA-290.
ARA 290 reduces inflammation and controls symptoms in Sarcoidosis by improving lung function and reducing inflammatory markers.
Clinical trials of ARA 290 and their results:

Peptide ARA-290 has undergone numerous clinical trials that prove its efficacy and safety.

One of the largest clinical trials included 204 participants with diabetic neuropathy. The results prove that therapy with ARA 290 leads to a significant improvement in neuropathic pain and helps reduce the symptoms of the disease.

Another study involved 90 people with fibromyalgia. It monitored a significant reduction in pain and a positive increase in the quality of life of the participants after administration of the peptide ARA290.

The results of another clinical trial, in which 290 people participated, prove that ARA 290 improves glucose metabolism in the brain, protects the nervous system from damage and accelerates wound healing.

All clinical trials of ARA 290 conducted so far give good and encouraging results for the treatment of various diseases.

Correct intake and dosage of ARA 290 16mg:

Peptide ARA 290 is a remedy that is used to treat various health conditions. The correct intake and dosage of this product are very important to achieve optimal therapeutic effect and reduce the risk of side effects.

The recommended dose of ARA290 is 3mg. to 4mg. daily (30-40 units), considering that one unit corresponds to 80mcg. The duration of the cycle may vary depending on the specific health condition and individual needs, but is usually taken for up to 2 months.